JP2023538761A5 - - Google Patents

Info

Publication number
JP2023538761A5
JP2023538761A5 JP2023513348A JP2023513348A JP2023538761A5 JP 2023538761 A5 JP2023538761 A5 JP 2023538761A5 JP 2023513348 A JP2023513348 A JP 2023513348A JP 2023513348 A JP2023513348 A JP 2023513348A JP 2023538761 A5 JP2023538761 A5 JP 2023538761A5
Authority
JP
Japan
Prior art keywords
formula
methyl
compound represented
thiapenta
propa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023513348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023538761A (ja
JP7818578B2 (ja
Filing date
Publication date
Priority claimed from GBGB2013383.1A external-priority patent/GB202013383D0/en
Application filed filed Critical
Publication of JP2023538761A publication Critical patent/JP2023538761A/ja
Publication of JP2023538761A5 publication Critical patent/JP2023538761A5/ja
Application granted granted Critical
Publication of JP7818578B2 publication Critical patent/JP7818578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023513348A 2020-08-26 2021-08-24 プロセス Active JP7818578B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2013383.1 2020-08-26
GBGB2013383.1A GB202013383D0 (en) 2020-08-26 2020-08-26 Process
PCT/EP2021/073378 WO2022043320A1 (en) 2020-08-26 2021-08-24 Process

Publications (3)

Publication Number Publication Date
JP2023538761A JP2023538761A (ja) 2023-09-11
JP2023538761A5 true JP2023538761A5 (https=) 2025-10-14
JP7818578B2 JP7818578B2 (ja) 2026-02-20

Family

ID=72660759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023513348A Active JP7818578B2 (ja) 2020-08-26 2021-08-24 プロセス

Country Status (13)

Country Link
US (1) US20230312506A1 (https=)
EP (1) EP4204407B1 (https=)
JP (1) JP7818578B2 (https=)
KR (1) KR20230058096A (https=)
CN (2) CN116209659A (https=)
BR (1) BR112023002055A2 (https=)
CO (1) CO2023003013A2 (https=)
ES (1) ES2985349T3 (https=)
GB (1) GB202013383D0 (https=)
IL (1) IL300613A (https=)
MX (1) MX2023002234A (https=)
PL (1) PL4204407T3 (https=)
WO (1) WO2022043320A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202105661D0 (en) * 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA987383B (en) * 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
JP2009535327A (ja) * 2006-04-25 2009-10-01 ディシュマン・ファーマシューティカルズ・アンド・ケミカルズ・リミテッド ロピバカイン塩酸塩無水物およびその調製
EP2850072B1 (en) * 2012-04-25 2016-08-31 Theravance Biopharma R&D IP, LLC Hepatitis c virus inhibitors
TWI610916B (zh) * 2012-08-03 2018-01-11 廣東東陽光藥業有限公司 作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
EP3049435A4 (en) * 2013-09-27 2017-03-29 Merck Sharp & Dohme Corp. Factor xia inhibitors
WO2015054087A1 (en) * 2013-10-07 2015-04-16 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途
EP4045491A1 (en) * 2019-10-17 2022-08-24 Givaudan SA Substituted azacyles as trmp8 modulators

Similar Documents

Publication Publication Date Title
NL192454C (nl) N,N'- digesubstitueerde ureum-, thioureum-, guanidine- en diaminoetheenderivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze derivaten bevatten.
JP2023538761A5 (https=)
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
JP2005526836A5 (https=)
JP2006524222A5 (https=)
JP2008511601A5 (https=)
RU2009132186A (ru) Способ получения соединений 2-аминотиазола в качестве ингибиторов киназы
RU2011129325A (ru) Циклическое карбодиимидное соединение
JP2007528883A5 (https=)
RU2005133994A (ru) Оксимные производные и их применение в качестве фармацевтически активных агентов
JP2005530811A5 (https=)
WO2015160772A1 (en) Tetrahydro-benzoimidazolyl modulators of tgr5
JP2024519815A5 (https=)
PE20040606A1 (es) 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados
JP2010534246A5 (https=)
SU479295A3 (ru) Способ получени -карбамилзамещенных -пиразолинов
RU2008119994A (ru) Ингибиторы калиевых каналов
RU2013129993A (ru) Новое производное пуринилпиридиниламино-2,4-дифторфенилсульфонамида, его фармацевтически приемлемая соль, способ его получения и фармацевтическая композиция, обладающая ингибирующей активностью в отношении raf-киназы, содержащая данное соединение в качестве активного ингредиента
WO2016142952A1 (en) Process for preparation of vilazodone and its novel intermediates
CZ295996B6 (cs) Způsob přípravy oxadiazinových derivátů
RU94036760A (ru) Производные триазина, его получение и использование
JP2006523626A5 (https=)
JP2021514399A5 (https=)
JP2023525601A5 (https=)
CN1942459A (zh) 浆果赤霉素ⅲ化合物的简易合成方法